Download Sample
Add to CartGlobal Small Molecule Drug Discovery Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
By Therapeutic Area;
Oncology, Central Nervous System Disorders, Cardiovascular Disorders, Respiratory Disorders, Metabolic Disorders, Gastrointestinal Disorders, Orthopedic Disorders, Immunological Disorders, Dermatology Disorders, Infectious Disease and Others.By Process Phase;
Target Identification/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Small Molecule Drug Discovery Market (USD Million), 2020 - 2030
In the year 2023, the Global Small Molecule Drug Discovery Market was valued at USD 37,458.77 million. The size of this market is expected to increase to USD 66,478.65 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 8.5%.
Global Small Molecule Drug Discovery Market Report Snapshot
| Parameters | Description |
|---|---|
| Market | Global Small Molecule Drug Discovery Market |
| Study Period | 2020 - 2030 |
| Base Year (for Small Molecule Drug Discovery Market Size Estimates) | 2023 |
| Drivers |
|
| Restraints |
|
| Opportunities |
|
Segment Analysis
This report extensively covers different segments of Global Small Molecule Drug Discovery Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Small Molecule Drug Discovery Segment Analysis
In this report, the Global Small Molecule Drug Discovery Market has been segmented by Therapeutic Area, Process Phase and Geography.
Global Small Molecule Drug Discovery Market, Segmentation by Therapeutic Area
The Global Small Molecule Drug Discovery Market has been segmented by Therapeutic Area into Oncology, Central Nervous System Disorders, Cardiovascular Disorders, Respiratory Disorders, Metabolic Disorders, Gastrointestinal Disorders, Orthopedic Disorders, Immunological Disorders, Dermatology Disorders, Infectious Disease and Others.
Global Small Molecule Drug Discovery Market, Segmentation by Process Phase
The Global Small Molecule Drug Discovery Market has been segmented by Process Phase into Target Identification/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization.
Global Small Molecule Drug Discovery Market, Segmentation by Geography
In this report, the Global Small Molecule Drug Discovery Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Small Molecule Drug Discovery Market Share (%), by Geographical Region, 2023
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Small Molecule Drug Discovery Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Competitive Landscape Analysis
Key players in Global Small Molecule Drug Discovery Market include:
- Pfizer, Inc
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Astrazeneca Plc
- Johnson & Johnson
- Boehringer Ingelheim Gmbh
- Teva Pharmaceutical Industries Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Takeda Pharmaceutical Company Ltd
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Process Phase
- Market Snapshot, By Region
- Global Small Molecule Drug Discovery Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Small Molecule Drug Discovery Market, By Therapeutic Area, 2020 - 2030 (USD Million)
- Oncology
- Central Nervous System Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Metabolic Disorders
- Gastrointestinal Disorders
- Orthopedic Disorders
- Immunological Disorders
- Dermatology Disorders
- Infectious Disease
- Others
- Global Small Molecule Drug Discovery Market, By Process Phase, 2020 - 2030 (USD Million)
- Target Identification/Validation
- Hit Generation and Selection
- Lead Identification
- Lead Optimization
- Global Small Molecule Drug Discovery Market, By Geography, 2020 - 2030 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Small Molecule Drug Discovery Market, By Therapeutic Area, 2020 - 2030 (USD Million)
- Competitive Landscape
- Company Profiles
- Pfizer, Inc
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Astrazeneca Plc
- Johnson & Johnson
- Boehringer Ingelheim Gmbh
- Teva Pharmaceutical Industries Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Takeda Pharmaceutical Company Ltd
- Company Profiles
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Small Molecule Prefilled Syringes Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Smart Healthcare Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Smart Healthcare Products Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Smart Medical Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%